Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
Completed clinical trial comparing empagliflozin versus GLP-1 receptor agonists on serious cardiovascular outcomes in Danish adults with typ…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm [NA]
A completed multi-center trial evaluating a novel implanted continuous glucose monitoring (CGM) system with a next-generation transmitter an…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD) [Phase 4]
Phase 4 trial update evaluating the effectiveness of a trivalent influenza vaccine in patients with type 2 diabetes, with and without chroni…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations
A clinical trial update pooling data from three studies on empagliflozin in diabetes or chronic heart failure analyzes the incidence of lowe…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Effects of Oral Magnesium Supplementation on Patients With Type 2 Diabetes [Phase 3]
Phase 3 clinical trial update evaluating the effects of oral magnesium supplementation in patients with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Online Diabetes Education Project (ODEP) [NA]
A completed clinical trial evaluating an online diabetes education program for type 2 diabetes; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) [Phase 4]
Phase 4 trial update evaluating finerenone effects on vascular stiffness and cardiorenal biomarkers in type 2 diabetes with chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities [Phase 4]
Phase 4 trial evaluating safety and effectiveness of saroglitazar 4 mg in patients with NAFLD and comorbidities.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin [Phase 2]
Phase 2 pilot studies evaluating the haemodynamic and metabolic effects of apelin and relaxin in cardiovascular disease and type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial investigating the effect of semaglutide on disordered eating behavior in patients with type 2 diabetes and overweight…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism [NA]
Clinical trial evaluating the effect of Androgel on atherogenesis in men with type 2 diabetes and hypogonadotrophic hypogonadism; study term…
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 trial update for PF-07081532 in adults with type 2 diabetes mellitus has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Feasibility Study on the Impact of Economic Incentives to Improve the Management of Type 2 Diabetes Mellitus [NA]
Feasibility study evaluating the impact of economic incentives on managing type 2 diabetes; completed with results posted in 2024.
-
FDA approval · 2024-01-24FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Ozempic to include the oral formulation of semaglutide. This adds an oral option alongside the e…
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease [Phase 4]
Phase 4 trial update for henagliflozin in patients with type 2 diabetes and nonalcoholic fatty liver disease.
-
FDA label_change · 2024-01-19FDA Approved: INVOKAMET — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental labeling application for INVOKAMET (canagliflozin and metformin hydrochloride) filed by Janssen Pharmaceutic…
-
FDA approval · 2024-01-19FDA Approved: INVOKAMET XR — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Invokamet XR (canagliflozin and metformin hydrochloride) from Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Amlexanox for Type 2 Diabetes and Obesity [Phase 2]
Phase 2 trial of amlexanox for type 2 diabetes mellitus and obesity was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Mobile Phone Support for Adults and Support Persons to Live Well With Diabetes [NA]
A completed clinical trial evaluating mobile phone support for adults with type 2 diabetes and their support persons; results posted in 2024…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM) [Phase 1]
Phase 1 trial of tirzepatide (LY3298176) in healthy participants and individuals with type 2 diabetes mellitus has completed with results po…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial evaluating paroxetine as adjunctive therapy to improve insulin sensitivity in adults with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes [Phase 1, Phase 2]
A completed Phase 1/2 trial comparing azithromycin and doxycycline for effects on resistin levels in patients with periodontitis and type 2 …
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide [Phase 1]
Phase 1 study evaluating the effect of tirzepatide on stomach emptying in overweight/obese individuals, including participants with Type 2 d…
-
FDA approval · 2024-01-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Laurus Labs Limited)
The FDA approved a supplemental application for metformin hydrochloride submitted by Laurus Labs Limited.
-
FDA approval · 2024-01-03FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for metformin hydrochloride from Sun Pharmaceutical Industries, Inc., confirming its status as an ap…